DAVID
DÍAZ VALLE
Profesor titular de universidad
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital Vall d'Hebron](/img/noimage_org.png)
Hospital Vall d'Hebron
Barcelona, EspañaHospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2023
-
SER recommendations for the treatment of uveitis
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477
2021
-
Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients
Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750
2019
-
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
American Journal of Ophthalmology, Vol. 200, pp. 85-94
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2016
-
Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain
Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152